Biomarkers that discriminate multiple myeloma patients with or without skeletal involvement detected using SELDI-TOF mass spectrometry and statistical and machine learning tools

33Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Multiple Myeloma (MM) is a severely debilitating neoplastic disease of B cell origin, with the primary source of morbidity and mortality associated with unrestrained bone destruction. Surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) was used to screen for potential biomarkers indicative of skeletal involvement in patients with MM. Serum samples from 48 MM patients, 24 with more than three bone lesions and 24 with no evidence of bone lesions were fractionated and analyzed in duplicate using copper ion loaded immobilized metal affinity SELDI chip arrays. The spectra obtained were compiled, normalized, and mass peaks with mass-to-charge ratios (m/z) between 2000 and 20,000 Da identified. Peak information from all fractions was combined together and analyzed using univariate statistics, as well as a linear, partial least squares discriminant analysis (PLS-DA), and a non-linear, random forest (RF), classification algorithm. The PLS-DA model resulted in prediction accuracy between 96-100%, while the RF model was able to achieve a specificity and sensitivity of 87.5% each. Both models as well as multiple comparison adjusted univariate analysis identified a set of four peaks that were the most discriminating between the two groups of patients and hold promise as potential biomarkers for future diagnostic and/or therapeutic purposes. © 2006 - IOS Press and the authors. All rights reserved.

References Powered by Scopus

Random forests

94856Citations
N/AReaders
Get full text

Partial least-squares regression: a tutorial

6297Citations
N/AReaders
Get full text

Use of proteomic patterns in serum to identify ovarian cancer

2937Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Trends in sample preparation for classical and second generation proteomics

156Citations
N/AReaders
Get full text

Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission

74Citations
N/AReaders
Get full text

Skeletal metastasis in renal cell carcinoma: Current and future management options

67Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bhattacharyya, S., Epstein, J., & Suva, L. J. (2006). Biomarkers that discriminate multiple myeloma patients with or without skeletal involvement detected using SELDI-TOF mass spectrometry and statistical and machine learning tools. In Disease Markers (Vol. 22, pp. 245–255). IOS Press. https://doi.org/10.1155/2006/728296

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

60%

Researcher 5

25%

Professor / Associate Prof. 2

10%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 7

39%

Computer Science 4

22%

Biochemistry, Genetics and Molecular Bi... 4

22%

Medicine and Dentistry 3

17%

Save time finding and organizing research with Mendeley

Sign up for free